Hayley Caronia

We just don't need it.

But the interest in Pfizer is going full steam ahead on Lyme disease.

This is the new interest, right?

So they are trying to get FDA approval for this new Lyme disease vaccine that failed a late stage trial.

But they did say that it reduced the rate of Lyme disease infection by more than 70% in people who received the vaccine versus the placebo.

And the company, Pfizer, says that this is good enough.

Even though it failed the last trial, it's good enough.

We'll send it over to the FDA and we'll get it regulated.

And the media is already falling into line, creating a fear of this year being even worse than last year when it comes to Lyme.

So like clockwork, bad year for Lyme.

Lyme disease experts predict another bad year.

And it just seems like, oh, it's just so perfect that they're coming out with a vaccine.

The bad year for Lyme.

They're going to have a Lyme disease vaccine.

How perfect.

Soon enough, it'll be like, save your grandma from Lyme disease.

Roll up your sleeves.

Nobody wants... Listen.

We saw the playbook play out in 2020 and in 2021.

They're going to do it again.